and viral exposure.' Among factors which may trigger exacerbations of multiple sclerosis the more commonly reported were viral infections,2A vaccinations,56 trauma,7 anaesthesia,8 physical overexertion,9 purperium,'°0' season,9 and stressful life circumstances.'2 13 In what proportion relapses in multiple sclerosis are triggered by an identifiable factor is still unsettled.
To investigate the role of potential risk factors in acute exacerbations, we designed a controlled one year study in patients with relapsing and remitting multiple sclerosis. Materials Overall, 59 cases and 50 controls reported an exposure to one or more potential risk factors in the preceding three months. Table 2 shows the occurrence of selected and total risk factors for both cases and controls. No significant differences were found between cases and controls for a single stressful life circumstance; cumulated stressful events were associated with a higher risk for subsequent exacerbation but this did not reach significance. A significantly higher percentage of controls (11) than cases (2) reported having had exposure to sudden environmental temperature variation. For the remaining risk factors we did not find any significant differences.
Discussion
We were unable to identify any candidate risk factor that may trigger exacerbations in multiple sclerosis. The low frequency of some risk factors in this study, such as trauma, physical overexertion, anaesthesia, and exposure to toxins, may have limited the capability to uncover potential weak associations between risk factors and relapses.
There is a lack of consensus about the effect of trauma on the exacerbation and the progression of the disease. McAlpine et al'4 and Walton"5 favoured the hypothesis that trauma must be considered a precipitating factor for exacerbation. In accord with other studies,7 16 we did not find a relation between traumatic episodes and most forms of physical trauma. Our data confirm previous studies which have not provided evidence that physical overexertion9 or anaesthesia8 are risk factors for disease exacerbation.
The possibility that vaccinations increase the risk of relapses in multiple sclerosis is debated. Riikonen"7 showed that the common vaccinations with live or inactivated viruses were often preceding events in relapses of multiple sclerosis. Bamford et al5 and more recently Salvetti et a16 showed a lower incidence of relapse in patients with multiple sclerosis treated with swine influenza vaccination and concluded that the use of a vaccine does not seem to influence the course of disease.
The role of stressful life circumstances on onset and exacerbations of multiple sclerosis was first studied by Pratt. He did not find a statistically significant difference between patients with multiple sclerosis and a nonmatched control group in their experience of life events.' 8 Franklin et By far the strongest environmental risk factors identified were virus-like infections. Sibley3 and Andersen et a14 found that in at risk periods-that is, from two weeks before an upper respiratory infection to five weeks afterwards, the multiple sclerosis exacerbation rate was higher than during not at risk periods. Panitch,19 recently, in a prospective study on viral infections and their correlation with multiple sclerosis attacks, found a strong correlation between multiple sclerosis exacerbations and upper respiratory infections. The lack of a relation between viral infections and exacerbations in our study can be explained by the different methodological approach used. Previous reports evaluated the relative risk of the exacerbations as annual relapse frequencies both in at risk and not at risk periods whereas our case-control study considered the association of a relapse with a viral infection verified in the previous three months.
Another concern in our study was the selection of cases and controls based only on clinical grounds. It is known that MRI in multiple sclerosis is more sensitive than clinical evaluation in detecting disease activity; new and enlarging lesions have often been seen in apparently clinically stable patients.20 Therefore, it may be possible that in some patients of our control group, the disease was active biologically but not clinically detectable.
In conclusion, the most important indication resulting from this study is the lack of strong relations between potential risk factors and exacerbations. Our data suggest a reassuring message for patients with multiple sclerosis. They should lead their lives without many of the restrictions advised by physicians until now.
